0000899243-22-010782.txt : 20220311 0000899243-22-010782.hdr.sgml : 20220311 20220311194835 ACCESSION NUMBER: 0000899243-22-010782 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220309 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tuckson Reed Vaughn CENTRAL INDEX KEY: 0001511051 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28386 FILM NUMBER: 22734783 MAIL ADDRESS: STREET 1: C/O UNITEDHEALTH GROUP INCORPORATED STREET 2: 9900 BREN ROAD EAST CITY: MINNETONKA STATE: MN ZIP: 55123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 800 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 800 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-09 0 0000891293 CTI BIOPHARMA CORP CTIC 0001511051 Tuckson Reed Vaughn 3101 WESTERN AVENUE, SUITE 800 SEATTLE WA 98121 1 0 0 0 Stock Option (right to buy) 4.49 2022-03-09 4 A 0 80000 0.00 A 2032-03-09 Common Stock 80000 80000 D This stock option vests on the first to occur of (i) the date that is twelve months after the date of grant, and (ii) immediately prior to the first annual meeting of the Company's stockholders in 2023 at which one or more members of the Company's Board of Directors are to be elected, subject to the Reporting Person's continued service through such date or event. /s/ Bruce J. Seeley, as attorney-in-fact for Reed V. Tuckson 2022-03-11